Boehringer to Acquire California Biotech Firm

21:45 PM | June 30, 2008 | Deepti Ramesh

Boehringer Ingelheim says it has agreed to acquire privately owned biopharmaceutical company Actimis Pharmaceuticals (San Diego) for as much as $515 million, depending on the successful development of...